| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 141.94% | Needham | → $3 | Reiterates | Buy → Buy |
| 11/13/2023 | 37.1% | Piper Sandler | $4 → $1.7 | Maintains | Neutral |
| 11/13/2023 | — | Citigroup | Downgrades | Buy → Neutral | |
| 11/10/2023 | — | Barrington Research | Downgrades | Outperform → Market Perform | |
| 11/10/2023 | 61.29% | Morgan Stanley | $3 → $2 | Maintains | Equal-Weight |
| 11/10/2023 | 141.94% | Needham | $9 → $3 | Maintains | Buy |
| 11/10/2023 | 20.97% | Cantor Fitzgerald | $5.3 → $1.5 | Downgrades | Overweight → Neutral |
| 10/23/2023 | 141.94% | Morgan Stanley | $4.5 → $3 | Maintains | Equal-Weight |
| 08/10/2023 | 593.55% | Goldman Sachs | $10 → $8.6 | Maintains | Buy |
| 08/10/2023 | 464.52% | Barrington Research | → $7 | Reiterates | Outperform → Outperform |
| 08/10/2023 | 222.58% | Piper Sandler | $6 → $4 | Maintains | Neutral |
| 08/09/2023 | 327.42% | Cantor Fitzgerald | $7.4 → $5.3 | Maintains | Overweight |
| 08/09/2023 | 383.87% | Credit Suisse | $7.5 → $6 | Maintains | Neutral |
| 08/09/2023 | 262.9% | Morgan Stanley | $6.5 → $4.5 | Maintains | Equal-Weight |
| 08/09/2023 | 625.81% | Needham | $15 → $9 | Maintains | Buy |
| 08/09/2023 | 222.58% | Baird | $12 → $4 | Downgrades | Outperform → Neutral |
| 05/31/2023 | 383.87% | BMO Capital | $9 → $6 | Maintains | Outperform |
| 05/17/2023 | 1109.68% | Needham | → $15 | Reiterates | Buy → Buy |
| 04/28/2023 | 625.81% | BMO Capital | $11 → $9 | Maintains | Outperform |
| 04/28/2023 | 706.45% | Goldman Sachs | $11.5 → $10 | Maintains | Buy |
| 04/27/2023 | 706.45% | Barrington Research | → $10 | Reiterates | → Outperform |
| 04/27/2023 | 504.84% | Credit Suisse | $9 → $7.5 | Maintains | Neutral |
| 04/27/2023 | 496.77% | Cantor Fitzgerald | → $7.4 | Upgrades | Neutral → Overweight |
| 04/27/2023 | 1109.68% | Needham | → $15 | Reiterates | → Buy |
| 04/27/2023 | 383.87% | Piper Sandler | $10 → $6 | Maintains | Neutral |
| 04/21/2023 | 424.19% | Morgan Stanley | $10 → $6.5 | Maintains | Equal-Weight |
| 04/06/2023 | 706.45% | Piper Sandler | → $10 | Reiterates | → Neutral |
| 03/31/2023 | 706.45% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 03/22/2023 | 666.13% | Cantor Fitzgerald | → $9.5 | Maintains | Neutral |
| 03/22/2023 | 625.81% | Credit Suisse | $11 → $9 | Maintains | Neutral |
| 03/22/2023 | 1109.68% | Needham | → $15 | Reiterates | → Buy |
| 02/06/2023 | 787.1% | BMO Capital | $9 → $11 | Maintains | Outperform |
| 02/06/2023 | 1109.68% | Barrington Research | $9 → $15 | Reiterates | → Outperform |
| 02/03/2023 | 666.13% | Cantor Fitzgerald | $8 → $9.5 | Reiterates | → Neutral |
| 02/03/2023 | 787.1% | Morgan Stanley | $10 → $11 | Maintains | Equal-Weight |
| 02/03/2023 | 1109.68% | Needham | → $15 | Reiterates | → Buy |
| 02/03/2023 | 706.45% | Piper Sandler | $7 → $10 | Maintains | Neutral |
| 01/10/2023 | 908.06% | Goldman Sachs | $14.4 → $12.5 | Maintains | Buy |
| 11/22/2022 | 545.16% | Credit Suisse | → $8 | Initiates Coverage On | → Neutral |
| 11/09/2022 | 625.81% | BMO Capital | $8 → $9 | Maintains | Outperform |
| 11/09/2022 | 706.45% | Morgan Stanley | $12 → $10 | Maintains | Equal-Weight |
| 11/08/2022 | 1061.29% | Goldman Sachs | $16.5 → $14.4 | Maintains | Buy |
| 11/08/2022 | 464.52% | Piper Sandler | $8 → $7 | Upgrades | Underweight → Neutral |
| 08/01/2022 | 867.74% | Morgan Stanley | $16 → $12 | Maintains | Equal-Weight |
| 07/29/2022 | 1109.68% | Needham | $19 → $15 | Maintains | Buy |
| 07/29/2022 | 545.16% | Piper Sandler | $9 → $8 | Maintains | Underweight |
| 07/25/2022 | 787.1% | Macquarie | → $11 | Downgrades | Outperform → Neutral |
| 05/25/2022 | 625.81% | Piper Sandler | $10 → $9 | Downgrades | Neutral → Underweight |
| 05/06/2022 | 1190.32% | Morgan Stanley | $17 → $16 | Maintains | Equal-Weight |
| 05/06/2022 | 706.45% | Piper Sandler | $15 → $10 | Maintains | Neutral |
| 05/06/2022 | 1432.26% | Needham | $28 → $19 | Maintains | Buy |
| 04/14/2022 | 1270.97% | Morgan Stanley | $22 → $17 | Maintains | Equal-Weight |
| 03/30/2022 | 867.74% | Cantor Fitzgerald | → $12 | Initiates Coverage On | → Neutral |
| 02/10/2022 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 02/10/2022 | 1270.97% | Berenberg | → $17 | Downgrades | Buy → Hold |
| 02/10/2022 | 2158.06% | Needham | $50 → $28 | Maintains | Buy |
| 02/02/2022 | 1916.13% | Goldman Sachs | $42 → $25 | Upgrades | Neutral → Buy |
| 01/27/2022 | 1835.48% | Morgan Stanley | $28 → $24 | Maintains | Equal-Weight |
| 01/13/2022 | 1754.84% | Piper Sandler | $37 → $23 | Downgrades | Overweight → Neutral |
| 12/09/2021 | 2158.06% | Morgan Stanley | $37 → $28 | Maintains | Equal-Weight |
| 11/10/2021 | 3932.26% | Needham | $61 → $50 | Maintains | Buy |
| 11/10/2021 | 2883.87% | Piper Sandler | $54 → $37 | Maintains | Overweight |
| 07/30/2021 | 4335.48% | Morgan Stanley | $53 → $55 | Maintains | Equal-Weight |
| 07/12/2021 | — | Macquarie | Upgrades | Neutral → Outperform | |
| 04/29/2021 | 4174.19% | Morgan Stanley | $55 → $53 | Maintains | Equal-Weight |
| 02/12/2021 | 4335.48% | Morgan Stanley | $42 → $55 | Maintains | Equal-Weight |
| 02/12/2021 | 4819.35% | Needham | $50 → $61 | Maintains | Buy |
| 02/12/2021 | 4738.71% | Piper Sandler | $49 → $60 | Maintains | Overweight |
| 01/26/2021 | 3287.1% | Morgan Stanley | $39 → $42 | Maintains | Equal-Weight |
| 11/24/2020 | 3045.16% | Morgan Stanley | → $39 | Initiates Coverage On | → Equal-Weight |
| 10/28/2020 | 3690.32% | Piper Sandler | $46 → $47 | Maintains | Overweight |
| 07/31/2020 | 3770.97% | Credit Suisse | $28 → $48 | Upgrades | Neutral → Outperform |
| 07/31/2020 | 3932.26% | Needham | $44 → $50 | Maintains | Buy |
| 07/16/2020 | 3932.26% | Jefferies | → $50 | Initiates Coverage On | → Buy |
| 06/30/2020 | 3932.26% | Citigroup | $28 → $50 | Maintains | Buy |
| 06/30/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 05/22/2020 | 3287.1% | Piper Sandler | → $42 | Initiates Coverage On | → Overweight |
| 05/21/2020 | 3448.39% | Needham | $30 → $44 | Maintains | Buy |
| 05/18/2020 | 3367.74% | BMO Capital | $31 → $43 | Maintains | Outperform |
| 05/04/2020 | 2319.35% | Baird | → $30 | Upgrades | Neutral → Outperform |
| 05/01/2020 | 2158.06% | Credit Suisse | $32 → $28 | Maintains | Neutral |
| 05/01/2020 | 2319.35% | Needham | $25 → $30 | Maintains | Buy |
| 03/25/2020 | 1916.13% | Needham | → $25 | Upgrades | Hold → Buy |
| 03/16/2020 | 2561.29% | BMO Capital | $26 → $33 | Upgrades | Market Perform → Outperform |
| 03/11/2020 | 2319.35% | Baird | $28 → $30 | Maintains | Neutral |
| 02/07/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 02/07/2020 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 11/13/2019 | 1996.77% | DA Davidson | $17 → $26 | Maintains | Neutral |
| 11/13/2019 | 1835.48% | BMO Capital | $20 → $24 | Maintains | Market Perform |
| 11/13/2019 | 2480.65% | Credit Suisse | $42 → $32 | Maintains | Neutral |
| 10/17/2019 | 1270.97% | DA Davidson | $27 → $17 | Maintains | Neutral |
| 09/25/2019 | 1754.84% | Keybanc | $37 → $23 | Maintains | Overweight |
| 08/08/2019 | 1512.9% | Citigroup | → $20 | Reinstates | → Buy |
| 08/08/2019 | 1512.9% | Citigroup | → $20 | Reinstates | → Buy |
| 08/01/2019 | 1270.97% | Berenberg | $81 → $17 | Downgrades | Buy → Hold |
| 07/31/2019 | — | Needham | Downgrades | Buy → Hold | |
| 07/31/2019 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 07/31/2019 | — | Macquarie | Downgrades | Outperform → Neutral | |
| 07/31/2019 | 2238.71% | Baird | $58 → $29 | Downgrades | Outperform → Neutral |
| 07/17/2019 | 4416.13% | Keybanc | → $56 | Initiates Coverage On | → Overweight |
| 05/08/2019 | 4738.71% | BMO Capital | $83 → $60 | Maintains | Outperform |
| 05/08/2019 | 4335.48% | Credit Suisse | $85 → $55 | Downgrades | Outperform → Neutral |
| 03/06/2019 | 8125.81% | Berenberg | → $102 | Initiates Coverage On | → Buy |
| 02/26/2019 | 6754.84% | Credit Suisse | $80 → $85 | Maintains | Outperform |
| 02/26/2019 | 6593.55% | BMO Capital | $72 → $83 | Maintains | Outperform |
| 02/26/2019 | 6351.61% | Keybanc | $65 → $80 | Maintains | Overweight |
| 01/08/2019 | 5141.94% | Keybanc | $80 → $65 | Maintains | Overweight |
What is the target price for 2U (TWOU)?
The latest price target for 2U (NASDAQ: TWOU) was reported by Needham on November 17, 2023. The analyst firm set a price target for $3.00 expecting TWOU to rise to within 12 months (a possible 141.94% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for 2U (TWOU)?
The latest analyst rating for 2U (NASDAQ: TWOU) was provided by Needham, and 2U reiterated their buy rating.
When is the next analyst rating going to be posted or updated for 2U (TWOU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 2U, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 2U was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating 2U (TWOU) correct?
While ratings are subjective and will change, the latest 2U (TWOU) rating was a reiterated with a price target of $0.00 to $3.00. The current price 2U (TWOU) is trading at is $1.24, which is within the analyst's predicted range.